Study selection
Studies were selected if they prospectively investigated the use of ELISA D-dimer tests in patients with suspected PE who presented to an emergency department or outpatient clinic. Reviews and editorials were excluded.
Data extraction
Data were extracted independently by 2 reviewers on study quality, patient characteristics, the diagnostic standard, and the sensitivity and specificity of the test.
Main results
11 studies involving 2126 patients met the selection criteria. The prevalence of PE ranged from 17-58%. The mean age range of patients was 54-81 years. Receiver operating characteristic curve analysis found significant heterogeneity among the studies. Pooling the results from the 11 studies using a random effects model resulted in high sensitivity and low specificity (table) . Subgroup analysis of the 9 studies that used traditional ELISA D-dimer methods (ie, not rapid ELISA methods) yielded similar results (table). Advanced patient age ( ≥ 70 y) resulted in lower specificity (14%). A prolonged duration of symptoms ( ≥ 3 d) decreased both sensitivity and specificity (1 study, 73% and 33%, respectively).
Conclusion
The enzyme linked immunosorbent assay D-dimer test is highly sensitive but not specific in diagnosing pulmonary embolism in an ambulatory clinical setting. 
COMMENTARY
Based on this sound meta-analysis by Brown et al, the role of D-dimer measurement as a diagnostic aid in patients with clinically suspected PE is confirmed. As initially suggested > 10 years ago, 1 a D-dimer level below a certain cut point rules out PE with a high predictive value, at least in patients with a low or moderate clinical probability.
Why is D-dimer useful in ruling out PE? Why not use diagnostic tests that are both sensitive and specific, such as pulmonary angiography or spiral computed tomography (CT)? The main reason is that the index of suspicion for PE has increased over the years, lowering its confirmed prevalence to ≤ 20% in clinically suspected populations. Thus, ruling out pulmonary embolism with a noninvasive, quick, and relatively inexpensive test has become a priority. Secondly, angiography and spiral CT are costly. Thus, sparing them in patients with a low D-dimer level should be cost effective, although this has not been shown formally.
Some limitations of D-dimer testing deserve attention. Firstly, it is not a stand alone test, and should be used as part of a diagnostic algorithm, which includes a clinical probability assessment.
2 Secondly, it is most useful in outpatients because certain comorbid conditions in hospital patients can increase D-dimer levels. Thirdly, this meta-analysis was restricted to studies that used ELISAs; recent studies suggest that some automated latex assays may also be highly sensitive to venous thromboembolism while other latex assays are not sensitive enough to rule out PE unless patients have a low clinical probability.
Considering these limitations, should the results of D-dimer testing be used to help determine the management of patients with suspected PE? According to a published clinical management study, 3 yes. However, further studies are needed to confirm that a negative D-dimer test result, when combined with a low or moderate clinical likelihood for PE, is associated with a low rate of thromboembolism that is similar to that seen with an established diagnostic standard, such as a normal ventilation perfusion lung scan.
